Francois Alhenc-Gelas

Title: The Innovations of Francois Alhenc-Gelas

Introduction

Francois Alhenc-Gelas is a notable inventor based in Paris, France. He has made significant contributions to the field of medical research, particularly in the area of hypertension. With a total of 2 patents, his work has had a profound impact on diagnostic methods and treatment options.

Latest Patents

One of his latest patents involves the nucleic acid coding for the human angiotensin converting enzyme (ACE). This invention relates to the cloning and sequencing of the nucleic acid coding for human ACE, as well as the determination of the peptide chain corresponding to ACE and the active peptide fragments derived from it. The patent also covers the utilization of these polypeptides for in vitro diagnostic methods for hypertension and the design of new ACE inhibitors. Additionally, it includes the use of nucleotide probes for in vitro screening of polymorphisms of the gene coding for ACE.

Career Highlights

Francois Alhenc-Gelas is affiliated with the Institut National de la Santé et de la Recherche Médicale, where he conducts his research. His work has been instrumental in advancing our understanding of ACE and its implications in hypertension.

Collaborations

He has collaborated with notable colleagues such as Florent Soubrier and Christine Hubert, contributing to the collective knowledge in the field of medical research.

Conclusion

Francois Alhenc-Gelas continues to be a significant figure in the realm of medical innovations, particularly through his patents related to ACE and hypertension. His contributions are vital for future advancements in diagnostic and therapeutic methods.